Abstract Context: The management of behavioral symptoms and rigidity in patients with dementia constitutes a significant challenge. Short-term studies suggest…
Abstract Background: Use of medical cannabis is increasing among older adults. However, few investigations have examined cannabis use in this…
Abstract Anxiety-related disorders are one of the most common mental health issues worldwide. Mexico has reported an increase in the…
Abstract Background: Patients use medical cannabis for a wide array of illnesses and symptoms, and many substitute cannabis for pharmaceuticals.…
Abstract Background: Medical cannabis (MC) has been hypothesized as an alternative therapy for migraines, given the undesirable side effects of…
Abstract Background and Aim: Limited data are available in clinical settings on the pharmacokinetics of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).…
Abstract Background: There is continued scientific debate regarding the link between risk of COVID-19 infection and increased disease severity and…
Abstract Aim: A case of an 85-year-old patient with concurrent use of warfarin and medical cannabis containing delta-9-tetrahydrocannabinol (THC) and…
Abstract Disease or acquired damage to the central nervous system frequently causes disabling spasticity and central neuropathic pain (NP), both…
Abstract Cannabidiol (CBD) is a promising therapeutic agent with analgesic, myorelaxant, and anti-epileptic actions. Recently, a purified form of CBD…